Home Health, Hospice, and Post-Acute Care

Introduction

Post-acute care sits at the intersection of two powerful trends: the aging population (which drives volume) and the payer imperative to reduce acute care costs (which drives policy support for lower-cost post-acute settings). For healthcare bankers, the three post-acute sub-sectors (home health, hospice, and skilled nursing) each have distinct reimbursement models, margin profiles, and investment dynamics that require separate analysis.

Home health agencies provide skilled nursing, physical therapy, occupational therapy, and other clinical services in the patient's home. The business is asset-light (no facilities beyond an office), labor-intensive, and primarily reimbursed by Medicare.

Patient-Driven Groupings Model (PDGM)

The Medicare reimbursement system for home health that replaced the previous Home Health Prospective Payment System in 2020. PDGM pays home health agencies a fixed amount per 30-day "period of care" (formerly 60-day episodes), with payment adjusted based on clinical grouping, functional impairment level, comorbidity, and admission source (community vs. institutional). PDGM eliminated therapy visit volume as a payment driver, which previously incentivized agencies to maximize therapy visits regardless of patient need. Under PDGM, payment is determined by patient characteristics at admission, shifting the economic incentive from visit volume to efficient care delivery within the 30-day period.

Economics: Home health operates at EBITDA margins of 8-15%, with labor (nurses, therapists, aides) representing 65-75% of costs. Revenue per episode under PDGM ranges from approximately $2,000 to $4,500 depending on patient acuity and geography. The business is highly scalable because it requires minimal capital investment (no facilities, no major equipment).

Key players: Amedisys (merged with UnitedHealth/Optum), LHC Group (acquired by UnitedHealth/Optum), Enhabit Home Health & Hospice, Encompass Health (home health spin-off), and thousands of smaller independent agencies.

Hospice provides end-of-life care (pain management, symptom control, emotional support) for patients with a terminal prognosis of six months or less. Hospice is overwhelmingly Medicare-funded (approximately 90% of revenue) and operates under a per diem reimbursement model.

Reimbursement: Medicare pays a daily rate that varies by level of care: Routine Home Care (~$215/day, accounting for ~97% of hospice days), Continuous Home Care (~$1,100/day), Inpatient Respite Care (~$190/day), and General Inpatient Care (~$1,100/day). The per diem rate covers all services, medications, and equipment related to the terminal diagnosis.

Economics: Hospice operates at EBITDA margins of 12-20%, higher than home health because of the per diem model's revenue predictability and the lower clinical intensity of routine hospice care (which is primarily nursing aide and social worker visits rather than skilled nursing). The key metric is average length of stay (ALOS), typically 70-90 days. Longer ALOS improves margins because early enrollment days (when patients are less acute) are more profitable under the per diem model. The average daily census (ADC), which measures how many patients are on service on any given day, is the primary volume metric for hospice operators. Growing ADC through community education, physician relationship development, and hospital discharge partnerships is the main organic growth lever.

Fragmentation and PE interest. There are approximately 5,500 Medicare-certified hospice providers in the US, with the top 10 operators controlling only about 15% of the market. This extreme fragmentation has made hospice a prime target for PE consolidation, with firms acquiring platforms at 10-14x EBITDA and executing add-on acquisitions at 8-11x. The asset-light model (hospice care is delivered in the patient's home or in contracted inpatient beds, requiring minimal facility investment) and the predictable Medicare per diem revenue stream make hospice financially attractive for leveraged acquisition structures.

The next article covers behavioral health, one of the fastest-growing PE consolidation verticals driven by payer coverage expansion.